Sign in Membership

Latest Briefings

Feb 05, 2025

Pioneering Value-Based Care in China: A Conversation with Dr. Felix Lee, Co-CEO of The GBA Healthcare Group

This success story emphasizes the importance of aligning healthcare innovation with a nation's infrastructure and social security framework to ensure practical, scalable, and sustainable care delivery and payment models.
Jan 02, 2025

The Future of Innovative Medicine Pricing and Reimbursement in China: Signals from the 2024 NRDL Negotiations

These developments call for a global pricing strategy rooted in China's evolving reimbursement infrastructure, breaking siloed thinking to balance short-term goals with long-term growth.
Dec 04, 2024

NHSA Strengthens Control Over Outpatient Spending

Effectively navigating these regulatory changes will have significant and lasting implications for drug manufacturers, particularly in shaping their pricing strategies, reimbursement models, and distribution channel approaches in China.
Nov 06, 2024

Advances in New Technology Add-On Payments for Innovative Medicine in China’s DRG/DIP Framework

In July, China’s National Healthcare Security Administration introduced the CHS-DRG Grouping Plan (Version 2.0), expanding the number of
Oct 15, 2024

▶️China's Medical Service Pricing Reform: Impact on Innovative Medical Technology Pricing and Adoption

Stay ahead of value-based approval and pricing trends for medical services and discover strategic growth opportunities to support clinical and commercial strategies for innovative medical technologies in China.
Oct 02, 2024

Capitalizing on Specialized Medical Services in China: Opportunities for Innovative Life Sciences Manufacturers

To take advantage of these opportunities, manufacturers must focus on three key success factors.
Aug 28, 2024

Three Key Trends Shaping Pricing for Innovative Non-VBP Medical Devices in China

Understanding and strategically applying these trends is crucial for optimizing pricing strategies and enhancing market adoption of innovative medical technologies in China.
Jul 10, 2024

5 Trillion-Yuan Equipment Renewal and China's National Quota System for Large Medical Equipment

In China, large medical equipment is managed through a planned allocation and permit system. Medical institutions must follow specific plans, meet clinical and functional requirements, and have the necessary technical infrastructure and qualified staff.
Jul 03, 2024

NHSA Quietly Releases Implementation Guides for Establishing Medical Service Pricing Items

In China, both public and private not-for-profit hospitals are required to adhere to the Medical Service Pricing Catalogs to provide
Jun 26, 2024

China Aims to Establish a High-Quality All-Inclusive Commercial Health Insurance System in Five Years

City Commercial Health Insurance ("Huiminbao") has been rapidly advancing, focusing on protecting the entire population against major illnesses,